Welcome to Critical Mass, Law.com's weekly briefing for class action and mass tort attorneys. What impact could the U.S. Supreme Court's decision not to review a $2.1 billion verdict have on talcum powder cases against Johnson & Johnson? Bayer's "five-point plan" on Roundup, announced last week, has some unremarkable — and remarkable — points. The federal judge who appointed a diverse team to lead the Zantac multidistrict litigation talked to Law.com about her career.

Feel free to reach out to me with your input. You can email me at [email protected], or follow me on Twitter: @abronstadlaw.